September 9, 2020 Life Science Tools Product Launch

PCR Biosystems launches RiboShield™ RNase Inhibitor to ensure reliable RNA protection

Caption: RiboShield™ RNase Inhibitor. Click images to download.  London, UK (09 September 2020) — PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product. RiboShield™ RNase Inhibitor is a recombinant protein that blocks the activity of a... Read more

September 9, 2020 Lab Top-10 M&A, Partnerships Product Launch

Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis

Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis Combines bioproduction and pharma services to accelerate innovation in biologics manufacturing WALTHAM, Mass., Sept. 9, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri. The facility... Read more

September 9, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

Roche expands its multiple sclerosis portfolio with investigational BTK inhibitor fenebrutinib and initiates novel clinical trials for OCREVUS (ocrelizumab)

Phase III clinical trial programme initiated for investigational medicine fenebrutinib, designed to be a highly selective and reversible Bruton’s tyrosine kinase (BTK) inhibitor, in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS) Phase IIIb clinical trial programme of higher-dose OCREVUS (ocrelizumab) to evaluate impact on reducing disability progression in RMS and PPMS OCREVUS CHIMES... Read more

September 8, 2020 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Life Science Tools

FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer

FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO CARLSBAD, Calif., Sept. 8, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a... Read more

September 8, 2020 Lab Top-10 PAI Top-10 PR/Corporate

Bruker Appoints Bonnie H. Anderson to its Board of Directors

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that it has appointed Bonnie H. Anderson to serve on its board of directors, effective as of September 3, 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200908005326/en/ (Photo: Business Wire) Ms. Anderson is Co-Founder, Chairman of the Board and CEO of Veracyte,... Read more

September 8, 2020 Lab Top-10 Microscopy

FBI Approves Thermo Fisher Scientific's Rapid DNA Solution for National DNA Index System

FBI Approves Thermo Fisher Scientific’s Rapid DNA Solution for National DNA Index System Applied Biosystems RapidHIT ID System plays key role in arrestee testing and investigative lead generation SOUTH SAN FRANCISCO, Calif., Sept. 8, 2020 /PRNewswire/ — The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific’s Applied Biosystems RapidHIT ID System for use... Read more

September 8, 2020 Acad, Gov/Utilities Microscopy PR/Corporate

Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients

Immunocompromised transplant patients are at risk of major complications when infected with BK virus cobas BKV test addresses critical need for hospitals and laboratories to have standardised and comparable results across institutions New Breakthrough Device test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus... Read more

September 7, 2020 Uncategorized

The following press release is in German language only – QIAGEN investiert mehr als 110 Mio. Euro in die Erhöhung der Produktions-kapazitäten für Coronavirus-Tests

Hilden, 8. September 2020 – QIAGEN hat heute angekündigt, mehr als 110 Mio. Euro in den Ausbau seiner Kapazitäten für die Fertigung von COVID-19-Testprodukten an den Standorten Hilden, Germantown (Maryland, USA) und Barcelona zu investieren. Mit dem bislang größten Investitionsprogramm in der Unternehmensgeschichte setzt QIAGEN seine Anstrengungen fort, den globalen Kampf gegen die Pandemie durch die Erhöhung von... Read more

September 7, 2020 Acad, Gov/Utilities Bio/Pharma/CRO

Roche announces FDA approval of Gavreto (pralsetinib) for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer

Gavreto is a once-daily, oral precision therapy that selectively inhibits RET-altered cancers Genentech and Blueprint Medicines will co-commercialise Gavreto in the United States FDA also granted Priority Review to Gavreto for the treatment of people with advanced or metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer              Basel, 7 September 2020 – Roche (SIX:... Read more